|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/095 | (2019.01) |
| A61K 9/0043 | (2013.01) | ||
| A61M 11/06 | (2006.01) | ||
| A61M 11/06 | (2013.01) | ||
| A61M 15/08 | (2006.01) | ||
| A61M 15/08 | (2013.01) | ||
| A61P 5/10 | (2006.01) | ||
| A61M 11/008 | (2014.02) | ||
| A61P 7/12 | (2006.01) | ||
| A61K 38/095 | (2019.01) | ||
| A61P 13/02 | (2006.01) | ||
| A61P 13/00 | (2018.01) | ||
| A61P 13/02 | (2018.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61P 5/10 | (2018.01) | ||
| A61P 7/12 | (2018.01) |
| (11) | Number of the document | 3679941 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19202083.2 |
| Date of filing the European patent application | 2010-06-15 | |
| (97) | Date of publication of the European application | 2020-07-15 |
| (45) | Date of publication and mention of the grant of the patent | 2022-08-10 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 26895409 P | 2009-06-18 | US |
| (72) |
FEIN, Seymour , US
|
| (73) |
Acerus Pharmaceuticals USA, LLC ,
500 Office Center Drive
Suite 400, Fort Washington, PA 19034,
US
|
| (54) | SAFE DESMOPRESSIN ADMINISTRATION |
| SAFE DESMOPRESSIN ADMINISTRATION |